Bloomwell CEO: Germany’s Cannabis Act Report Proves No Reason for Stricter Laws
Germany’s Cannabis Act evaluation shows fewer youth consumers, no rise in accidents, and declining crime. Bloomwell CEO Niklas Kouparanis warns against restricting medical access, arguing it would re-criminalize patients and undermine public health progress.
